MENU
+Compare
HLUBF
Stock ticker: OTC
AS OF
Apr 14 closing price
Price
$3.70
Change
+$0.04 (+1.09%)
Capitalization
4.85B

HLUBF H. Lundbeck A/S Forecast, Technical & Fundamental Analysis

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products... Show more

HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for HLUBF with price predictions
Jul 02, 2025

HLUBF in upward trend: price rose above 50-day moving average on June 20, 2025

HLUBF moved above its 50-day moving average on June 20, 2025 date and that indicates a change from a downward trend to an upward trend. In of 10 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for HLUBF crossed bullishly above the 50-day moving average on June 20, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 7 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.363) is normal, around the industry mean (62.813). P/E Ratio (11.947) is within average values for comparable stocks, (89.433). HLUBF's Projected Growth (PEG Ratio) (8.689) is very high in comparison to the industry average of (2.987). Dividend Yield (0.020) settles around the average of (0.124) among similar stocks. P/S Ratio (1.511) is also within normal values, averaging (19.290).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. HLUBF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HLUBF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
HLUBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Ottiliavej 9
Phone
+45 36301311
Employees
5450
Web
https://www.lundbeck.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CFNEX87.380.34
+0.39%
American Funds Fundamental Invs 529E
DFSPX14.980.03
+0.20%
DFA Intl Sustainability Core 1
INDAX17.45N/A
N/A
ALPS/Kotak India ESG Inv
TSQIX13.01N/A
N/A
AMG TimesSquare Small Cap Growth I
ABECX22.18-0.02
-0.09%
American Beacon The London Co Inc Eq C

HLUBF and Stocks

Correlation & Price change

A.I.dvisor tells us that HLUBF and HLBBF have been poorly correlated (+18% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HLUBF and HLBBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
HLBBF - HLUBF
18%
Poorly correlated
+12.15%
HLNCF - HLUBF
7%
Poorly correlated
+1.95%
ESAIY - HLUBF
5%
Poorly correlated
N/A
AKAN - HLUBF
2%
Poorly correlated
-2.26%
HLN - HLUBF
1%
Poorly correlated
-0.87%
More

Groups containing HLUBF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLUBF
1D Price
Change %
HLUBF100%
N/A
Pharmaceuticals
category (297 stocks)
13%
Poorly correlated
+0.68%
Pharmaceuticals: Other
category (203 stocks)
10%
Poorly correlated
+1.03%